Nasdaq ctso.

Cytosorbents Corporation (NASDAQ: CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings …About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, ...5 Sep 2023 ... Alexander D'Amico, CFO at CytoSorbents Corporation (Nasdaq: CTSO), a critical care therapy provider, has resigned from his position as part ...Cytosorbents Corp (NASDAQ:CTSO) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more …

PRINCETON, N.J., Aug. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using ...

Jun 2, 2022 · 02 Jun, 2022, 07:00 ET. PRINCETON, N.J., June 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit ... Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings expectations. Reported EPS is $-0.20718 EPS, expectations were ...

With 6.1% and 4.9% of the shares outstanding respectively, BlackRock, Inc. and The Vanguard Group, Inc. are the second and third largest shareholders. Furthermore, CEO Phillip Chan is the owner of ...CTSO CTSO AFTER HOURS QUOTE CTSO LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ... Cytosorbents (NASDAQ:CTSO) was awarded a Defense Health Agency Small Business Technology Transfer (STTR) Phase III contract valued at up to $2.9 million over a two-year period, enabling CTSO to ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.On Invalid Date, . Cytosorbents (NASDAQ: CTSO) reported Q3 2023 earnings per share (EPS) of -$0.21, up 25% year over year. Total Cytosorbents earnings for the quarter were -$9.19 million.In the same quarter last year, Cytosorbents's earnings per share (EPS) was …

Nov 14, 2023 · CytoSorbents (NASDAQ:CTSO) reported 3rd quarter 2023 results on November 9th which showed strong product revenue growth. 3rd quarter product revenues increased 20% to $7.8 million and grant income ...

March 20, 2023 at 7:38 AM · 3 min read. It is doubtless a positive to see that the Cytosorbents Corporation ( NASDAQ:CTSO) share price has gained some 204% in the last three months. But that is ...

About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...Find the latest Financials data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com.About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.Jul 19, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings expectations. Reported EPS is $-0.20718 EPS, expectations were ...As of August 2, 2023, the average one-year price target for Cytosorbents is 8.57. The forecasts range from a low of 5.56 to a high of $16.80. The average price target represents an increase of 155 ...

25.63%. Get the latest Cytosorbents Corp (CTSO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Find the latest Cytosorbents Corporation (CTSO) stock quote, history, news and other vital information to help you with your stock trading and investing.About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...Find the latest SEC Filings data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com.צפה בגרף ‎Cytosorbents Corporation‎ בזמן אמת כדי לעקוב אחר תנועת מחיר המניה. תמצא תחזיות שוק, ‎CTSO‎ וחדשות שוק כלכליות.The CTSO shares have gain 5.98% over the last week, with a monthly amount drifted -36.08%, and not seem to be. At the time of writing, Cytosorbents Corp [CTSO] stock is trading at $1.24, down -4.62%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The CTSO …

Cytosorbents Corp (NASDAQ:CTSO) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for CTSO is 81.9. Stocks with ...

PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...The bid-ask spread can indicate a stock's liquidity, which is how easy it is to buy and sell in the marketplace. Often, a smaller spread suggests higher ...Cytosorbents Corporation (NASDAQ: CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings …Sep 1, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.Find the latest Financials data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com. MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi... Menu icon A vertical stack of three evenly ...CytoSorbents Corporation (NASDAQ: CTSO) is a leader in the treatment of life-threatening conditions using blood purification. CytoSorbents’ flagship product, CytoSorb®, is approved in the ...

Of the 27 institutional investors that sold Cytosorbents stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($0.57M), Redmile Group LLC ($0.33M), Northern Trust Corp ($0.31M), Goldman Sachs Group Inc. ($0.24M), CM Management LLC ($0.23M), Sargent …

Apr 13, 2021 · A look at the shareholders of Cytosorbents Corporation (NASDAQ:CTSO) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership.

Every investor in Cytosorbents Corporation (NASDAQ:CTSO) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it's not ...Find the latest Cytosorbents Corporation (CTSO) stock quote, history, news and other vital information to help you with your stock trading and investing.About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.Cytosorbents Co. (NASDAQ:CTSO – Free Report) – Stock analysts at Zacks Small Cap decreased their FY2023 EPS estimates for shares of Cytosorbents in a research report issued to clients and investors on Tuesday, November 14th. Zacks Small Cap analyst T. Kerr now expects that the medical research company will post earnings of ($0.61) per share […]Oct 5, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... PRINCETON, N.J., Jan. 17, 2023 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...Read Our Latest Report on Cytosorbents. Cytosorbents Stock Performance. NASDAQ CTSO opened at $1.24 on Thursday. The stock has a market cap of $55.11 million, a P/E ratio of -2.34 and a beta of 0.79.Jan 31, 2023 · CTSO CytoSorbents Corporation CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue PR Newswire PRINCETON, N.J., Jan. 31, 2023 Cumulative CytoSorb treatments surpassed 195,000.... See the latest CytoSorbents Corp stock price (NASDAQ:CTSO), related news, valuation, dividends and more to help you make your investing decisions.MONMOUTH JUNCTION, N.J., June 9, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that it was ...

Cytosorbents Corporation Common Stock (CTSO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings expectations. Reported EPS is $-0.20718 EPS, expectations were ...Instagram:https://instagram. turbo tax alternativescrm target pricebest b2b sales trainingzcaler stock See the latest CytoSorbents Corp stock price (NASDAQ:CTSO), related news, valuation, dividends and more to help you make your investing decisions.Stock Screener Earnings Calendar Sectors Nasdaq | CTSO U.S.: Nasdaq Cytosorbents Corp. Watch Set a price target alert After Hours Last Updated: Nov 16, 2023 4:33 p.m. EST Delayed quote $... vtv dividend2x dow etf About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...In this article we will take a look at whether hedge funds think Cytosorbents Corp (NASDAQ:CTSO) is a good investment right now. We check hedge fund and billionaire investor sentiment before ... how much is a 1979 coin dollar worth By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT CytoSorbents (NASDAQ:CTSO) reported 3rd quarter 2023 results on November 9th which showed strong product revenue growth. 3rd quarter product revenues increased 20% to $7.8 million and grant income decreased 35.9%. The increase in the Euro to U.S. dollar exchange rate positively impacted product sales by approximately $508,000. TheCytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology. CytoSorbents ...